Experts Susan J. Schniepp, distinguished fellow for Regulatory Compliance Associates, and Steven J. Lynn, executive vice-president, Pharmaceuticals for Regulatory Compliance Associates, discuss the verification of compendial methods.
Steven J. Lynn
Advertisement
Steven J. Lynn is executive vice-president, pharmaceuticals for Regulatory Compliance Associates, Inc.
Articles by Steven J. Lynn
Experts Susan J. Schniepp, distinguished fellow for Regulatory Compliance Associates, and Steven J. Lynn, executive vice-president, Pharmaceuticals for Regulatory Compliance Associates, provide answers to frequently asked regulatory questions about advanced therapy medicinal products.
With appropriate planning and the proper use of technology, remote auditing can be as effective and informative as in-person auditing.
Advertisement
Latest Updated Articles
Conducting Effective Audits During and Post PandemicPublished: February 1st 2021 | Updated:
- GMPs for Emerging Therapies
Published: August 1st 2021 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
4
Selecting the Right Drug Delivery Formulations to Enhance Patient-Centric Care
5
